News Archive

Events for the below selected month

Head & Neck Cancer Patient Treated with Innovative Radiotherapy Treatment

Posted

30 June 2019

UK first

A woman from Salisbury has become the first patient in the UK with head and neck cancer to receive radiotherapy in the operating theatre during surgery to remove a recurrent tumour. Jayne Garrett, 53, underwent major surgery at University...

Head & Neck cancer patient receives radiotherapy during surgery

Posted

28 June 2019

BAHNO members involved in UK first

A woman has become the first patient in the UK with head & neck cancer to receive radiotherapy during surgery to remove a recurrent tumour. Jayne Garrett underwent major surgery at University Hospital, Southampton after suffering a recurrence of...

ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer

Posted

05 June 2019

Media release: The Institute of Cancer Research, London

Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show. At diagnosis, people with head and...

The Waterside Ape - an alternative account of human evolution

Posted

03 June 2019

New book available by Mr Peter Rhys Evans

Have you ever wondered why humans have such an affinity for water and the sea, unlike any other primate? Why some people have dark skin and others have paler skin? Why we lost our fur and are the only Naked Ape? Why, out of over 4,000 land...

Professor Maura L Gillison presents at BAHNO

Posted

20 May 2019

Packed auditorium hears American Professor’s lecture

Professor Maura L Gillison was the Blair Hesketh invited speaker at the recent BAHNO Annual Scientific Meeting. Over 300 delegates listened to her presentation on the management of HPV and oropharyngeal cancer and a lively case-based panel...

The President’s Awards

Posted

20 May 2019

Outstanding surgeons recognised

At his final AGM as President of BAHNO, Professor Hisham Mehanna took the opportunity to honour four surgeons who have contributed greatly to BAHNO and to the specialty. Mr Michael Fardy and Mr Nicholas Roland were given Honorary Life Membership...

Doctors team up to treat 'untreatable growth' - and the results are 'miraculous'

Posted

10 May 2019

Patient told his condition was incurable until two Teesside surgeons stepped in to change his life

Fantastic news from Teesside! Please read the article here. From Teesside Live NHS.

FAQ Discussion Guide for Patients Diagnosed with Head & Neck Cancer launched

Posted

01 May 2019

Make Sense Campaign launches booklet for patients

A diagnosis of head and neck cancer can be shocking and in the following weeks will have you navigating through your medical system. During this time, conversations with your healthcare professionals will be intense and, sometimes, short, but you...

BAHNO Annual Scientific Meeting

Posted

18 April 2019

Friday 17th May 2019

The BAHNO meeting this year has been accredited 6 CPD points by the Royal College of Surgeons of England. Register here Registrations on the day will incur a £50 administrative charge!

Dynamic host immune response in virus-associated cancers

Posted

29 March 2019

Abstract Viruses drive carcinogenesis in human cancers through diverse mechanisms that have not been fully elucidated but include promoting immune escape. Here we investigated associations between virus-positivity and immune pathway alteration...

Non-murine models to investigate tumor-immune interactions in head and neck cancer

Posted

29 March 2019

On-line article

The immune response has important roles in the biology of solid tumors, including oncogenesis, tumor growth, invasion and metastasis, and response to treatment. Improved understanding of tumor-immune system interactions has provided promising...

Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach

Posted

29 March 2019

From the British Journal of Cancer

Background TNM8 staging for oropharyngeal squamous cell carcinomas (OPSCC) surrogates p16 immunohistochemistry for HPV testing. Patients with p16+ OPSCC may lack HPV aetiology. Here, we evaluate the suitability of TNM8 staging for guiding...

Summary of the European public assessment report (EPAR) for Erbitux

Posted

29 March 2019

European Medicines Agency

This is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and...

Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cance

Posted

29 March 2019

Case report from the United States

Methods We reviewed current statistics and the medical and legal literature regarding inbound medical tourism and the process of obtaining a visa for patients traveling to the United States for medical treatment. To illustrate this process, we...

Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma

Posted

15 March 2019

Scientific Report

Recently, exosomes secreted by menstrual mesenchymal stem cells have been identified as inhibitory agents of tumor angiogenesis and modulators of the tumor cell secretome in prostate and breast cancer. However, their direct effect on endothelial...

Bill introduced to make oral cancer medication more affordable

Posted

15 March 2019

News from America

WASHINGTON, D.C. — There’s a new effort on Capitol Hill to make newer cancer treatment options more affordable. U.S. Senator Tina Smith (D-Minnesota) along with U.S. Senator Jerry Moran (R-Kansas) re-introduced the “Cancer Drug Parity Act”...

The NKG2A immune checkpoint

Posted

15 March 2019

A new direction in cancer immunotherapy

Inhibition of the NKG2A immune checkpoint restores natural killer cell and T cell effector function in preclinical cancer models. In addition, NKG2A blockade in combination with other therapeutic antibodies is showing encouraging responses in a...

Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy

Posted

15 March 2019

Hopes for earlier diagnosis and better survival outcome in patients with head and neck cancer.

Patients with head and neck squamous cell carcinoma are at increased risk of developing a second primary malignancy, which is associated with poor prognosis and early death. To help improve clinical outcome, we aimed to identify biomarkers for...

Depiction of Oral Tumor-Induced Trigeminal Afferent Responses Using Single-Fiber Electrophysiology

Posted

15 March 2019

Considerable gap in knowledge exists about the mechanisms by which oral tumors regulate peripheral sensory fibers to produce pain and altered sensations. To address this gap, we used a murine model of oral squamous cell carcinoma (OSCC) of the...

BAHNO Research Grants

Posted

04 March 2019

Two awards given this year

BAHNO is pleased to announce that, due to the high standard of applications, the Research Committee has decided to make two awards this year. The recipients are: Paula Bradley (University of Sunderland) - who will receive £3,000 to develop...

Back to News Home